Intestinal nutrient absorption reduction

"Intestinal nutrient absorption reduction" is not the name of a specific molecule, protein, receptor, enzyme, or transporter. Instead, it describes the broad physiological process by which the uptake of nutrients from the intestinal lumen into enterocytes and subsequently into circulation is decreased. This can occur through various mechanisms—such as inhibition of transporters like SGLT1 for glucose/galactose or GLUT5 for fructose—or by altering gut motility and mucosal function[1][2][3]. However, "intestinal nutrient absorption reduction" itself does not refer to any single canonical drug target. Rather, it encompasses multiple possible targets and pathways involved in digestion and absorption processes within the small intestine. In summary: The entry "Intestinal nutrient absorption reduction" is too broad and non-specific to be considered a valid therapeutic target according to standard nomenclature conventions. It should be replaced with more precise terms referring to individual molecules such as "Sodium/glucose cotransporter 1 (SGLT1)", "Glucose transporter type 5 (GLUT5)", etc., depending on context[1].